Literature DB >> 19125411

Depletion of CD4(+)CD25(+) T cells exacerbates experimental autoimmune encephalomyelitis induced by mouse, but not rat, antigens.

Eitan M Akirav1, Cheryl M Bergman, Myriam Hill, Nancy H Ruddle.   

Abstract

A key question in the field of autoimmunity concerns the fact that experimental disease is generally induced more easily with closely related, but not completely identical, tissue-restricted antigens. Here, the possibility that naturally occurring regulatory T cells (Tregs) for self-antigens are more potent than those for related antigens was investigated. The self-antigen specificity of naturally occurring Tregs was tested in experimental autoimmune encephalomyelitis (EAE) induced with mouse (self) or closely related (rat) myelin oligodendrocyte glycoproteins (MOGs). Surprisingly, Treg depletion increased EAE severity in mice immunized with mouse, but not rat, MOG. This increase was associated with increased T-cell activation and infiltration of the central nervous system, as well as increased interleukin (IL)-17 production and a higher ratio of interferon-gamma- to IL-10-producing cells. These data suggest that Tregs are specific for self-antigen and do not "cross-protect" against autoimmunity even when disease is induced with closely related foreign antigens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19125411      PMCID: PMC4429897          DOI: 10.1002/jnr.21981

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  30 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Experimental autoimmune encephalomyelitis induced in B6.C-H-2bm12 mice by myelin oligodendrocyte glycoprotein: effect of MHC class II mutation on immunodominant epitope selection and fine epitope specificity of encephalitogenic T cells.

Authors:  I Mendel; H Gur; N Kerlero de Rosbo; A Ben-Nun
Journal:  J Neuroimmunol       Date:  1999-04-01       Impact factor: 3.478

3.  Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice.

Authors:  Emma L Masteller; Matthew R Warner; Qizhi Tang; Kristin V Tarbell; Hugh McDevitt; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice.

Authors:  Harald H Hofstetter; Klaus V Toyka; Magdalena Tary-Lehmann; Paul V Lehmann
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

5.  Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.

Authors:  Cecilia B Marta; Alfred R Oliver; Rebecca A Sweet; Steven E Pfeiffer; Nancy H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

6.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

7.  B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide.

Authors:  J A Lyons; M San; M P Happ; A H Cross
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

8.  The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells.

Authors:  Richard A O'Connor; Katy H Malpass; Stephen M Anderton
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

9.  Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.

Authors:  Katharina Lahl; Christoph Loddenkemper; Cathy Drouin; Jennifer Freyer; Jon Arnason; Gérard Eberl; Alf Hamann; Hermann Wagner; Jochen Huehn; Tim Sparwasser
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

10.  A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Authors:  Caroline Sutton; Corinna Brereton; Brian Keogh; Kingston H G Mills; Ed C Lavelle
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  10 in total

1.  Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology.

Authors:  Daniel Larocque; Nicholas S R Sanderson; Josée Bergeron; James F Curtin; Joe Girton; Mia Wibowo; Niyati Bondale; Kurt M Kroeger; Jieping Yang; Liliana M Lacayo; Kevin C Reyes; Catherine Farrokhi; Robert N Pechnick; Maria G Castro; Pedro R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

2.  Oestrogen-mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory T cells implicates compensatory pathways including regulatory B cells.

Authors:  Sandhya Subramanian; Melissa Yates; Arthur A Vandenbark; Halina Offner
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

3.  Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.

Authors:  Hong Dai; Bogoljub Ciric; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2012-02-25       Impact factor: 3.478

4.  Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies.

Authors:  Rajiv W Jain; Amy K Dang; Steven M Kerfoot
Journal:  J Vis Exp       Date:  2016-10-27       Impact factor: 1.355

5.  Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease.

Authors:  Xuebin Liu; Stewart Leung; Chunxia Wang; Zhu Tan; Ji Wang; Taylor B Guo; Lei Fang; Yonggang Zhao; Bing Wan; Xia Qin; Limin Lu; Runsheng Li; Heng Pan; Mingjuan Song; Ailian Liu; Jian Hong; Hongtao Lu; Jingwu Z Zhang
Journal:  Nat Med       Date:  2010-01-10       Impact factor: 53.440

6.  Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages.

Authors:  Sung Won Lee; Hyun Jung Park; Sung Ho Jeon; Changjin Lee; Rho Hyun Seong; Se-Ho Park; Seokmann Hong
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  Effect of Cordyceps sinensis on the Treatment of Experimental Autoimmune Encephalomyelitis: A Pilot Study on Mice Model.

Authors:  Shan-Shan Zhong; Ya-Juan Xiang; Pen-Ju Liu; Yang He; Ting-Ting Yang; Yang-Yang Wang; A Rong; Jun Zhang; Guang-Zhi Liu
Journal:  Chin Med J (Engl)       Date:  2017-10-05       Impact factor: 2.628

8.  A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit experimental autoimmune encephalomyelitis (EAE).

Authors:  Cody D Moorman; Alexander G Bastian; Kayla B DeOca; Mark D Mannie
Journal:  J Neuroinflammation       Date:  2020-06-10       Impact factor: 8.322

Review 9.  Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.

Authors:  Neil H Riordan; Thomas E Ichim; Wei-Ping Min; Hao Wang; Fabio Solano; Fabian Lara; Miguel Alfaro; Jorge Paz Rodriguez; Robert J Harman; Amit N Patel; Michael P Murphy; Roland R Lee; Boris Minev
Journal:  J Transl Med       Date:  2009-04-24       Impact factor: 5.531

10.  Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic Background.

Authors:  Asmita Pradeep Yeola; Prenitha Mercy Ignatius Arokia Doss; Joanie Baillargeon; Irshad Akbar; Benoit Mailhot; Mohammad Balood; Sébastien Talbot; Ana Carrizosa Anderson; Steve Lacroix; Manu Rangachari
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.